BP-5-087 [1803281-30-2]

TargetMol Chemicals

BP-5-087 [1803281-30-2]

72

Research Use Only

BP-5-087

C36H30F8N2O6S

770.69

BP-5-087 is a STAT3 inhibitor, combining with BCR-ABL1 inhibition to overcome kinase-independent resistance in chronic myeloid leukemia.

3 years

N(CC1=CC=C(C=C1)C2CCCCC2)(C(CN(CC3=C(F)C(F)=C(F)C(F)=C3F)S(=O)(=O)C4=CC=C(C(F)(F)F)C=C4)=O)C5=CC(O)=C(C(O)=O)C=C5

-20°C

12352200